Noxap (Nitric Oxide)

Nitric Oxide, the active ingredient in Noxap, is a pulmonary vasodilator presented as an inhalation gas for inhalation use. It is used to manage pulmonary hypertension and improve oxygenation in specific clinical settings. GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Noxap is a pulmonary vasodilator that acts on the pulmonary vascular resistance pathway.

- Pulmonary hypertension: reduces vascular resistance and supports right‑ventricular function. - Acute respiratory distress syndrome (ARDS): improves ventilation‑perfusion matching. - Peri‑operative pulmonary hypertension management: stabilises haemodynamics during surgery. - Neonatal persistent pulmonary hypertension of the newborn (PPHN): facilitates transition to extra‑uterine life. - Post‑cardiac surgery pulmonary hypertension: aids in weaning weaning . - Adult cardiac  ");

Common